Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug AdministrationS Brown, M. Miles Braun, Mark H. Greene et al.|Arthritis & Rheumatism|2002Cited by 661
Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanerceptJong‐Hoon Lee, M. Miles Braun, Nancy R. Slifman et al.|Arthritis & Rheumatism|2002Cited by 448